Search results
Author(s):
Eduardo Back Sternick
,
Mariana Faustino
,
Frederico Soares Correa
,
et al
Added:
3 years ago
Radiofrequency (RF) catheter ablation is currently the treatment of choice in patients with accessory pathways (APs) and Wolff– Parkinson–White syndrome, and is shown to have a success rate >95 %.1 APs usually have endocardial ventricular and atrial insertions, located close to the atrioventricular valve rings, making most endocardial catheter ablation procedures relatively straightforward and…
View more
Author(s):
Fouad Khalil
,
Konstantinos C Siontis
,
Gabor Bagameri
,
et al
Added:
3 years ago
Catheter-based ablation has been a well-established tool in the treatment of ventricular tachycardia (VT). However, the effectiveness of catheter ablation may be limited by its ability to access sites of arrhythmogenic tissue and achieve adequate lesion size in target areas without risking collateral damage. Antiarrhythmic surgery would be an effective alternative in such situations. Despite the…
View more
Author(s):
Laurent Roten
,
Matthew Daly
,
Patrizio Pascale
,
et al
Added:
3 years ago
With an ageing population and widespread use of implantable cardioverter-defibrillators, physicians are confronted with an increasing number of patients with symptomatic, drug-refractory ventricular tachycardia (VT). Catheter ablation is an important treatment option in the management of patients with structural heart disease and VT.1,2 In many patients, VT can be successfully ablated from the…
View more
Author(s):
Eyal Nof
,
William G Stevenson
,
Roy John
Added:
3 years ago
Sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) are typically a manifestation of significant structural heart disease and often associated with a high risk of sudden cardiac death. Implantable cardioverter defibrillators (ICDs) remain the mainstay of therapy for prevention of sudden cardiac death associated with these arrhythmias.1 However, ICDs treat the arrhythmia after…
View more
Author(s):
Mario Njeim
,
Frank Bogun
Added:
3 years ago
Percutaneous ablation for ventricular tachycardia (VT) was first attempted in 1983 and has rapidly evolved to become an important option for controlling recurrent VTs.1 Endocardial ablation remained the only percutaneous approach until epicardial access was introduced by Sosa et al. in 1996 and thereafter became progressively more available as an adjunctive strategy for the treatment of…
View more
Author(s):
Takumi Yamada
,
G Neal Kay
Added:
3 years ago
Idiopathic ventricular arrhythmias (IVAs) usually originate from the specific anatomical structures. For the past decade, major IVA origins from both endocardial and epicardial sites have been increasingly recognised (see Table 1).1–3 Catheter ablation of IVAs is usually safe and highly successful, but can sometimes be challenging because of the anatomical obstacles. Therefore, understanding the…
View more
Convergent AF Ablation
Author(s):
Karan Wats
,
Andy Kiser
,
Kevin Makati
,
et al
Added:
3 years ago
Article
Author(s):
Amit J Thosani
,
Paul Gerczuk
,
Emerson Liu
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide. In 2010, the prevalence of AF in the US was estimated at 5.9 million.1 The decision to pursue treatment to maintain sinus rhythm is driven by disabling symptoms related to AF; including palpitations, dyspnoea, fatigue, stroke and congestive heart failure. Percutaneous catheter-based ablation is an established therapy for…
View more
Author(s):
Riyaz Kaba
,
Omar Ahmed
,
Elijah R Behr
,
et al
Added:
1 year ago
Author(s):
David DeLurgio
,
Jaswinder Gill
,
Syed Ahsan
,
et al
Added:
2 years ago